This inventor holds 1 USPTO granted patent. Top assignee: Medicines for Malaria Venture (Mmv). Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations in Antimalarial Treatments by Yuanqing Tang
Introduction
Yuanqing Tang is a notable inventor based in Omaha, NE (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial treatments. Her innovative work focuses on creating effective and non-toxic compounds to combat malaria and other diseases.
Latest Patents
Yuanqing Tang holds a patent for "Spiro and dispiro 1,2,4-trioxolane antimalarials." This patent describes a means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane. The preferred compounds include a spiroadamantane group on one side of the trioxolane group and a spirocyclohexyl on the other side. The spirocyclohexyl ring is preferably substituted at the 4-position. Compared to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites. Yuanqing Tang has 1 patent to her name.
Career Highlights
Yuanqing Tang is associated with Medicines for Malaria Venture (MMV), where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of malaria, contributing to global health initiatives.
Collaborations
Yuanqing has collaborated with notable colleagues, including Jonathan L Vennerstrom and Yuxiang Dong. These partnerships have enhanced her research and expanded the impact of her innovations in the field.
Conclusion
Yuanqing Tang's contributions to antimalarial treatments exemplify the importance of innovation in addressing global health challenges. Her work not only advances scientific knowledge but also offers hope for effective treatments against malaria and related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile